APP and Alzheimer disease: Hmo-cys F+ mice were hybridized with APP/PS1 mice to obtain APP/PS1/Hmo-cys F+ mice via double transgenics to mimic the high cystatin F levels observed in the monocytes of AD patients (Fig. 2B-D).